Alzheimer Disease Clinical Trials in Seoul
8 recruitingSeoul, South Korea
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled241 locationsNCT06937229
Recruiting
Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Alzheimer Disease
Karuna Therapeutics406 enrolled278 locationsNCT06585787
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
Alzheimer Disease
Bristol-Myers Squibb352 enrolled140 locationsNCT07011745
Recruiting
Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)
DementiaAlzheimer DiseaseMild Cognitive Impairment+1 more
Ewha Womans University Mokdong Hospital4,000 enrolled3 locationsNCT06889818
Recruiting
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2 (KBASE2)
Alzheimer DiseaseMild Cognitive Impairment
Seoul National University Hospital640 enrolled2 locationsNCT05138263
Recruiting
Phase 1
A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People
Alzheimer Disease
Pharmacobio100 enrolled1 locationNCT06367426
Recruiting
Phase 4
Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
Alzheimer Disease
Daewoong Bio Inc.630 enrolled4 locationsNCT05383183